e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Marcos M.A., Jimenez de Anta M.T., de la Bellacasa J.P., Gonzalez J., Martinez E., Garcia E., Mensa J., de Roux A., Torres A.
Source:
Eur Respir J 2003; 21: 209-214
Journal Issue:
February
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marcos M.A., Jimenez de Anta M.T., de la Bellacasa J.P., Gonzalez J., Martinez E., Garcia E., Mensa J., de Roux A., Torres A.. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 2003; 21: 209-214
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
Sputum and streptococcus pneumoniae urinary antigen test for diagnosis of pneumococcal community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Performance of the binax NOW
Streptococcus pneumoniae
urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Severe
Chlamydia pneumoniae
community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
The relationship between the result of urinary antigen detection kit for
Streptococcus pneumoniae
and clinical effect of treatment in patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Monitoring of
Mycoplasma pneumoniae
and
Chlamydia pneumoniae
in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Community-acquired pneumonia
Source: Respipedia Article
Year: 2017
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept